Abstract:

As a complement to imaging and cytology-based screening strategies, molecular diagnostics of lung cancer include not only the early detection but also the prognosis index and prediction of target therapy. In this paper, gene mutation, prediction of target therapy, miRNA, cancer stem cells and methylation in molecular diagnostics of lung cancer are reviewed.

Key words: gene mutation, target therapy, miRNA, cancer stem cell, methylation